Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800156797> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2800156797 endingPage "360" @default.
- W2800156797 startingPage "355" @default.
- W2800156797 abstract "Abstract Dalfampridine is a medication that is approved by the US Food and Drug Administration to improve walking impairments in patients with multiple sclerosis (MS). The branded dalfampridine is enormously expensive; hence, the availability of generic dalfampridine will provide better access to the medication, especially for uninsured patients with MS. Bioequivalence studies are demanded by the regulatory authorities to allow the marketing of new generics of dalfampridine. The aim of this study was to assess the bioavailability of the generic (test) and branded (reference) formulations of 10 mg dalfampridine of extended‐release tablets after oral administration to healthy adults under fed conditions. The current report methodology was based on a comparative, randomized, single‐dose, 2‐way crossover open‐label study design. Twenty‐seven subjects were given a single dose of the test dalfampridine tablet and completed the clinical study. The pharmacokinetic parameters C max and AUC 0→t, K el , AUC 0→∞ , t max , and t 1/2el were estimated to prove bioequivalence. The confidence intervals for the log‐transformed test/reference ratios for dalfampridine 100.96% (97.09%–104.97%) and 99.77% (95.81%–103.87%) for C max and AUC 0→∞ , respectively, were within the allowed limit specified by the regulatory authorities (80%–125%). Hence, clinically, the test tablet can be prescribed as an alternative to the reference for the indication of improving walking impairments in patients with MS." @default.
- W2800156797 created "2018-05-17" @default.
- W2800156797 creator A5010647908 @default.
- W2800156797 creator A5046360427 @default.
- W2800156797 creator A5053095507 @default.
- W2800156797 creator A5056983071 @default.
- W2800156797 creator A5058078198 @default.
- W2800156797 date "2018-05-11" @default.
- W2800156797 modified "2023-09-27" @default.
- W2800156797 title "Comparative Randomized, Single‐Dose, Two‐Way Crossover Open‐Label Study to Determine the Bioequivalence of Two Formulations of Dalfampridine Tablets" @default.
- W2800156797 cites W134576514 @default.
- W2800156797 cites W1732973804 @default.
- W2800156797 cites W1980168320 @default.
- W2800156797 cites W1981740502 @default.
- W2800156797 cites W1999835476 @default.
- W2800156797 cites W2000900321 @default.
- W2800156797 cites W2013234597 @default.
- W2800156797 cites W2051274614 @default.
- W2800156797 cites W2066137041 @default.
- W2800156797 cites W2089473160 @default.
- W2800156797 cites W2101529665 @default.
- W2800156797 cites W2105055889 @default.
- W2800156797 cites W2132855425 @default.
- W2800156797 cites W2209840531 @default.
- W2800156797 cites W2235497281 @default.
- W2800156797 cites W2254682149 @default.
- W2800156797 cites W2288073912 @default.
- W2800156797 cites W2417320783 @default.
- W2800156797 cites W2753423482 @default.
- W2800156797 cites W4229510354 @default.
- W2800156797 doi "https://doi.org/10.1002/cpdd.574" @default.
- W2800156797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29749716" @default.
- W2800156797 hasPublicationYear "2018" @default.
- W2800156797 type Work @default.
- W2800156797 sameAs 2800156797 @default.
- W2800156797 citedByCount "0" @default.
- W2800156797 crossrefType "journal-article" @default.
- W2800156797 hasAuthorship W2800156797A5010647908 @default.
- W2800156797 hasAuthorship W2800156797A5046360427 @default.
- W2800156797 hasAuthorship W2800156797A5053095507 @default.
- W2800156797 hasAuthorship W2800156797A5056983071 @default.
- W2800156797 hasAuthorship W2800156797A5058078198 @default.
- W2800156797 hasConcept C112705442 @default.
- W2800156797 hasConcept C126322002 @default.
- W2800156797 hasConcept C142724271 @default.
- W2800156797 hasConcept C181389837 @default.
- W2800156797 hasConcept C204787440 @default.
- W2800156797 hasConcept C27081682 @default.
- W2800156797 hasConcept C3018890749 @default.
- W2800156797 hasConcept C3020385749 @default.
- W2800156797 hasConcept C42404028 @default.
- W2800156797 hasConcept C44249647 @default.
- W2800156797 hasConcept C71924100 @default.
- W2800156797 hasConcept C87813604 @default.
- W2800156797 hasConcept C98274493 @default.
- W2800156797 hasConceptScore W2800156797C112705442 @default.
- W2800156797 hasConceptScore W2800156797C126322002 @default.
- W2800156797 hasConceptScore W2800156797C142724271 @default.
- W2800156797 hasConceptScore W2800156797C181389837 @default.
- W2800156797 hasConceptScore W2800156797C204787440 @default.
- W2800156797 hasConceptScore W2800156797C27081682 @default.
- W2800156797 hasConceptScore W2800156797C3018890749 @default.
- W2800156797 hasConceptScore W2800156797C3020385749 @default.
- W2800156797 hasConceptScore W2800156797C42404028 @default.
- W2800156797 hasConceptScore W2800156797C44249647 @default.
- W2800156797 hasConceptScore W2800156797C71924100 @default.
- W2800156797 hasConceptScore W2800156797C87813604 @default.
- W2800156797 hasConceptScore W2800156797C98274493 @default.
- W2800156797 hasIssue "3" @default.
- W2800156797 hasLocation W28001567971 @default.
- W2800156797 hasLocation W28001567972 @default.
- W2800156797 hasOpenAccess W2800156797 @default.
- W2800156797 hasPrimaryLocation W28001567971 @default.
- W2800156797 hasRelatedWork W2353450705 @default.
- W2800156797 hasRelatedWork W2356170336 @default.
- W2800156797 hasRelatedWork W2357220270 @default.
- W2800156797 hasRelatedWork W2360418234 @default.
- W2800156797 hasRelatedWork W2363093019 @default.
- W2800156797 hasRelatedWork W2373452970 @default.
- W2800156797 hasRelatedWork W2374069256 @default.
- W2800156797 hasRelatedWork W2380091905 @default.
- W2800156797 hasRelatedWork W2380433639 @default.
- W2800156797 hasRelatedWork W2391752688 @default.
- W2800156797 hasVolume "8" @default.
- W2800156797 isParatext "false" @default.
- W2800156797 isRetracted "false" @default.
- W2800156797 magId "2800156797" @default.
- W2800156797 workType "article" @default.